Clinical Trial Update: PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PSMA PET/CT-guided intensification of therapy for patients at risk of advanced prostate cancer. The study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING